Cancer progression

Expanding the potential of epigenetic therapies in prostate cancer

Queen's University Belfast

School of Medicine, Dentistry and Biomedical Sciences

Location
Belfast, United Kingdom
Funding
See university guidance
Application deadline
See university guidance

About the project

The work in our group focuses on the impact of altered nucleotide metabolism and epigenetics in cancer progression and the impact of standard of care therapeutics and novel agents in modulating these processes. Our aim is to contribute to the understanding on the molecular biology level and provide preclinical rational for the translation of our findings to clinical trials to improve patient care.

  • Dr Melissa LaBonte Wilson: School of Medicine, Dentistry and Biomedical Sciences

Contact info

  • View Academic Profile
  • askmhls@qub.ac.uk
  • +44 (0)28 9097 2789

Research Interests

Open to PhD applications in the field of

Make a PhD enquiry

  • Investigate key processes involved in the underlying biology driving epigenetic alterations
  • Nucleotide metabolism in cancer development
  • Novel drug targeting of these processes through in vitro cell line-based models and in vivo cancer mouse models.

Research students

PhD Title | Expanding the potential of epigenetic therapies in prostate cancer

Country | UK

Discover More

  • Faculty of Medicine, Health and Life Sciences
  • School of Medicine, Dentistry and Biomedical Sciences

Research areas

Cancer progressionEpigeneticsCancer

Related PhD opportunities